Global Active Implantable Medical Devices Market to Witness 8% CAGR during 2017 – 2023

According to a new market research report “Global Active Implantable Medical Devices Market Size, Share, Development, Growth and Demand Forecast to Industry Insight by Product (Implantable Cardioverter Defibrillators, Neurostimulators, Implantable Cardiac Pacemakers, Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders)” published by P&S Market Research, the global Active Implantable Medical Devices market is projected to reach $28,878.6 million by 2023, growing at a CAGR of 8.0% during Access Report Description at: analysis/active-implantable-medical-devices-market analysis/active-implantable-medical-devices-market Global Active Implantable Medical Devices Market

According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market. Global active implantable medical devices market was worth $16,990.8 million in 2016 Global Active Implantable Medical Devices Market

As per the findings of research, implantable cardioverter defibrillators held the largest share in the global active implantable medical devices market in 2016, primarily due to the development of technologically advanced devices and increasing prevalence of cardiovascular diseases. The neurostimulators market is expected to witness the highest growth during the forecast period. This growth of neurostimulators is attributed to the increasing incidence of neurological disorders and increasing demand from emerging economies. Among different type of implantable cardioverter defibrillators, transevenous implantable cardioverter defibrillators held larger share in the global active implantable medical devices market in 2016, and it is also expected to witness higher growth during the forecast period. Increasing research and development activities and rising compliance for technological innovations and data driven customizations are driving the growth of the global transvenous implantable cardioverter market. Among different types of neurostimulators, spinal cord stimulators contributed the largest revenue to the global neurostimulators market in Spinal cord stimulators market witnessed significant penetration across all geographies globally. Increasing number of failed-back surgery syndrome, refractory angina pectoris, peripheral vascular disease, and complex regional pain syndrome are the key factors leading to the increased demand for spinal cord stimulators. Insights on market segments Global Active Implantable Medical Devices Market

Geographically, North America has been the largest market for active implantable medical devices, with the U.S. being the larger contributor to the regional market as compared to Canada. The key factor driving the North American active implantable medical devices market are technological advancements, high healthcare expenditure, growing geriatric population, improved healthcare infrastructure and growing prevalence of cardiovascular diseases. The emerging economies in Asia-Pacific, especially China and India, are expected to grow tremendously in future, which is expected to bring the Asia-Pacific market approximately equal to the European market by Asia-Pacific presents several growth opportunities for the active implantable medical devices manufacturers due to the rapid expansion of healthcare industry in the region. North America stands as the largest active implantable medical devices market Global Active Implantable Medical Devices Market

Neurostimulation technology involves the usage of microelectrodes to activate nerves in the nervous system. A neurostimulation device is powered by battery and is a stopwatch sized device. It is surgically implanted in the brain and helps in generating paresthesia, a tingling sensation at the scheduled time intervals to the nervous system. These electric signals develop a sensation in the damaged nerves and help in treating chronic pain and neurological disorders. In case of chronic pain conditions, these electrical signals help in blocking the pain messages from nerves to reach brain. These devices are generally used in cases, where drug therapies are not effective. Increasing incidents of neurological disorders and the rising demand for minimally invasive procedures are leading to the increased demand for neurostimulators. The rapid penetration of neurostimulators market in the emerging economies is expected to have significant impact on the growth of the global active implantable medical devices market. Increasing adoption of neurostimulation technology to have high impact on the global active implantable medical devices market Global Active Implantable Medical Devices Market

Key companies in the active implantable medical devices market are acquiring other companies to strengthen their position in the global market. In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., including its atrial fibrillation, structural heart and heart failure business as well as neuromodulation business. Similarly, in January 2015, Medtronic plc completed the acquisition of Covidien plc. Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. The acquisition strengthened position of the company in the global market with a large number of product offerings. Some of the other key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL. Acquisition, a major development strategy for key players to strengthen their position in the global market Global Active Implantable Medical Devices Market

implantable-medical-devices-market/report-sample Download report sample at: Global Active Implantable Medical Devices Market

For information regarding permissions and other queries Kindly write to: US/Canada Toll-Free: GET IN TOUCH THANK YOU!